Spectral Medical Inc. makes diagnostic and therapeutic products for endotoxic septic shock and is based in Toronto, Canada.
Founded in 1991 and headquartered in Toronto, Canada, Spectral Medical Inc. develops solutions for endotoxic septic shock. Its products include the Endotoxin Activity Assay, a diagnostic tool, and Toraymyxin, a hemoperfusion device that removes endotoxins from the blood. On July 21, 2021, the company raised CAD 10 million in a PIPE round with investors including Birch Hill Equity Partners and Toray Engineering Co., Ltd. Chris Seto is the CEO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in